EVALUATION OF THE EFFECTIVENESS OF TOPICAL TREATMENT COMBINATION OF BETAMETHASONE DIPROPIONATE 0.05%/CALCIPOTRIOL MONOHYDRATE 0.005% GEL AND CLOBETASOLE PROPIONATE 0.05% OINTMENT IN PATIENTS WITH PSORIATIC ONYCHODYSTROPHY
- 作者: Maximov I.1, Kochergin N.1, Novoselov V.1, Ushakova D.1
-
隶属关系:
- Department of Dermatology and Venereology of I.M. Sechenov First Moscow State Medical University (Sechenov University)
- 期: 卷 22, 编号 5-6 (2019)
- 页面: 156-160
- 栏目: Articles
- URL: https://journals.rcsi.science/1560-9588/article/view/42952
- DOI: https://doi.org/10.17816/dv42952
- ID: 42952
如何引用文章
全文:
详细
作者简介
Ivan Maximov
Department of Dermatology and Venereology of I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: maximov.is@mail.ru
assistant of the Department of Dermatology and Venereology, I.M. Sechenov First Moscow State Medical University, Moscow, 119991, Russian Federation Moscow, 119991, Russian Federation
N. Kochergin
Department of Dermatology and Venereology of I.M. Sechenov First Moscow State Medical University (Sechenov University)Moscow, 119991, Russian Federation
V. Novoselov
Department of Dermatology and Venereology of I.M. Sechenov First Moscow State Medical University (Sechenov University)Moscow, 119991, Russian Federation
D. Ushakova
Department of Dermatology and Venereology of I.M. Sechenov First Moscow State Medical University (Sechenov University)Moscow, 119991, Russian Federation
参考
- Parisi R., Symmons D.P., Griffiths C.E., Ashcroft D.M. Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J. Inves.t Dermatol. 2013; 133(2): 377-85.
- Reich K. Approach to managing patients with nail psoriasis. J. Eur. Acad. Dermatol. Venereol. 2009; 23(Suppl. 1): 15-21.
- Pasch M.C. Nail psoriasis: a review of treatment options. Drugs. 2016; 76(6): 675-705.
- de Jong E.M., Seegers B.A., Gulinck M.K., Boezeman J.B., van de Kerkhof P.C. Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients. Dermatology. 1996; 193(4): 300-3.
- Lawry M. Biological therapy and nail psoriasis. Dermatol. Ther. 2007; 20(1): 60-7.
- Jiaravuthisan M.M., Sasseville D., Vender R.B., Murphy F., Muhn C.Y. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J. Am. Acad. Dermatol. 2007; 57(1): 1-27.
- Salomon J., Szepietowski J.C., Proniewicz A. Psoriatic nails: a prospective clinical study. J. Cutan. Med. Surg. 2003; 7(4): 317-21.
- Maejima H., Taniguchi T., Watarai A., Katsuoka K. Evaluation of nail disease in psoriatic arthritis by using a modified nail psoriasis severity score index. Int. J. Dermatol. 2010; 49(8): 901-6.
- Langenbruch A., Radtke M.A., Krensel M., Jacobi A., Reich K., Augustin M. Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis. Br. J. Dermatol. 2014; 171(5): 1123-8.
- Williamson L., Dalbeth N., Dockerty J.L., Gee B.C., Weatherall R., Wordsworth B.P. Extended report: nail disease in psoriatic arthritis - clinically important, potentially treatable and often overlooked. Rheumatology (Oxford). 2004; 43(6): 790-4.
- Augustin M., Reich K., Blome C., Schafer I., Laass A., Radtke M.A. Nail psoriasis in Germany: epidemiology and burden of disease. Br. J. Dermatol. 2010; 163(3): 580-5.
- Klaassen K.M., Dulak M.G., van de Kerkhof P.C., Pasch M.C. The prevalence of onychomycosis in psoriatic patients: systematic review. J. Eur. Acad. Dermatol. Venereol. 2014; 28(5): 533-74.
- Gupta A.K., Lynde C.W., Jain H.C., Sibbald R.G., Elewski B.E., Daniel C.R., et al. A higher prevalence of onychomycosis in psoriatics compared with non-psoriatics: a multicentre study. Br. J. Dermatol. 1997; 136(5): 786-9.
- Blauvelt A., Armstrong A.W., Krueger G.G. Essential truths for the care and management of moderate-to-severe psoriasis. J. Drugs Dermatol. 2015; 14(8): 805-12.
- Crowley J.J., Weinberg, J.M., Wu J.J., Robertson A.D., Van Voorhees A.S.; National Psoriasis Foundation. Treatment of nail psoriasis: best practice recommendations from the Medical Board of the National Psoriasis Foundation. JAMA Dermatol. 2015; 151(1): 87-94.
- Saki N., Hosseinpoor S., Heiran A., Mohammadi A., Zeraatpishe M. Comparing the efficacy of triamcinolone acetonide iontophoresis versus topical calcipotriol/betamethasone dipropionate in treating nail psoriasis: A bilateral controlled clinical trial. Dermatol. Res. Pract. 2018; 2018: 2637691. doi: 10.1155/2018/2637691.
- Tan E.S., Oon H.H. Effective treatment of severe nail psoriasis using topical calcipotriol with betamethasone dipropionate gel. Indian J. Dermatol. Venereol. Leprol. 2016; 82(3): 345-7.
- Arango-Duque L.C., Roncero-Riesco M., Usero Barcena T., Palacios Alvarez I., Fernandez Lopez E. Treatment of nail psoriasis with Pulse Dye Laser plus calcipotriol betametasona gel vs. Nd:YAG plus calcipotriol betamethasone gel: An intrapatient left-to-right controlled study. Actas Dermosifiliogr. 2017; 108(2): 140-4.
- Rigopoulos D., Gregoriou S., Daniel Iii C.R., Belyayeva H., Larios G., Verra P., et al. Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment. Dermatology. 2009; 218(4): 338-41.
- De Simone C., Maiorino A., Tassone F., D’Agostino M., Caldarola G. Tacrolimus 0.1% ointment in nail psoriasis: a randomized controlled open-label study. J. Eur. Acad. Dermatol. Venereol. 2013; 27(8): 1003-6.
- Boontaveeyuwat E., Silpa-Archa N., Danchaivijitr N., Wongpraparut C. A randomized comparison of efficacy and safety of intralesional triamcinolone injection and clobetasol propionate ointment for psoriatic nails. J. Dermatol. Treat. 2019; 30(2): 117-22.
- Brown M.B., Khengar R.H., Turner R.B., Forbes B., Traynor M.J., Evans C.R., et al. Overcoming the nail barrier: A systematic investigation of ungual chemical penetration enhancement. Int. J. Pharm. 2009; 370(1-2): 61-7.